Press Release

Liver Disease Diagnostics and Treatment Market Size, Share, Key Players Overview and Geographical Outlook 2026

Liver Disease Diagnostics and Treatment Market Size, Share, Opportunities, Development and Global Trend Analysis till 2026

The rising prevalence of liver cancer is promoting the growth of the global liver disease diagnostics and treatment market predicts Fortune Business Insights in their new study. The study is titled “Liver Disease Diagnostics and Treatment Market Size, Share and Global Trend By Treatment ( Anti-Viral Drugs, Vaccines, Chemotherapy, Targeted Therapy, Immunosuppressant, Immunoglobulins), By Diagnosis (Imaging, laboratory Tests, Endoscopy, Biopsy, Others), By End User (Hospitals, Clinics, Diagnostic Laboratories, Others), and Geography Forecast till 2026.”  This report focusses on major factors driving and restricting the growth of the market during the forecast period of 2019 to 2026.

Browse Complete Report:

Top Leaders Overview:

Some of the leading companies in the global Liver Disease Diagnostics and Treatment Market are

  • Pfizer
  • Novartis
  • Abbott
  • Johnson & Johnson
  • Hoffmann-La Roche
  • Bayer
  • Merck
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Mylan

According to the report, the market is dominated by the imaging segment based on diagnosis segment. This is because of the rise in technological advancement in liver diseases diagnosis and treatment procedures.This, coupled with, rise in popularity of non-invasive imaging techniques, will help this segment gain high revenue in the forecast period.

Changing Lifestyle and Spread of Smoking and Drinking Habits to Propel Growth

The American Cancer Society had projected that about more than 30,610 males and 11,610 females in the U.S. to be diagnosed with liver diseases by the end of 2018. The most prominent reason behind this is the rise in cases of obesity. In underdeveloped nations however the presence of unmet clinical need for liver diseases is likely to fuel the demand for liver disease diagnostics and treatment. In addition to this the rise in disposable income of the people is expected to aid the expansion of the market as they are more likely to willingly spend on advanced treatment. Furtermore, the widespread adoption of unhealthy lifestyle is identified as key growth driver for the global liver disease diagnostics and treatment market.

Get Sample PDF:

Additionally, the increasing prevalence of acute and chronic diseases of the liver such as biliary atresia, autoimmune hepatitis, cirrhosis, hepatitis A, B, and C, liver cancer,  and others, are boosting the global liver disease diagnostics and treatment market. In many developing nations, lack of awareness and availability of proper treatment facilities for liver diseases are anticipated to propel liver diseases diagnostics and treatment  market.

However, side-effects related to liver diseases treatment post-surgery and risk of infection from open wound may impede the growth of the market to an extent. Furthermore, strict rules and regulations implemented  on the use of liver treatment medication and the risks associated with them may also cause hindrance to the growth of the market in the forecast period.

Major Segmental Overview:

  • By Test Type
  • By Application
  • By End User
  • By Geography

Increasing Awareness and Improvement in Healthcare Facilities Will Help Market Exhibit Strong Growth in Asia Pacific

At present, North America is dominating the global liver diseases diagnostics and treatment market, according to Fortune Business Insights. This dominance is likely to continue in the forecast period owing to the rising prevalence of liver disease because of irregular eating habits and rising consumption of alcohol witnessed in the region. The surge in adoption of novel diagnostic procedures and therapeutic approaches is more likely to help North America remain dominant in the coming years.

Meanwhile, the liver disease treatment market in the Asia Pacific is likely to register a faster growth on account of developing healthcare infrastructure in the region, especially in the developing nations. Besides this, the spread of awareness programs supported by governments will help inform and educate people about the availability of liver diagnostics.

Some of the companies functioning in the global market are F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Bayer AG, Abbott, Bristol-Myers Squibb Company, Novartis AG, Merck & Co. Inc., Johnson & Johnson Services, Inc., Mylan N.V., Pfizer Inc., and others.

Speak to Analyst:


What is the market size and growth rate of the global and regional market by various segments?

What is the market size and growth rate of the market for selective countries?

Which region or sub-segment is expected to drive the market in the forecast period?

What Factors are estimated to drive and restrain the market growth?

What are the key technological and market trends shaping the market?

What are the key opportunities in the market?

What are the key companies operating in the market?

Which company accounted for the highest market share?

Why Choose Fortune Business Insights?

View Related Reports:

Kombucha Market Size, Share, Opportunities, Development and Global Trend Analysis till 2026

Instant Noodles Market Size, Share, Segmentation and Forecast 2019-2026

Wearable Medical Devices Market Share to Reach USD 139353.6 Mn by 2026 | Top Companies Fitbits, SugarBeat , SAMSUNG, Apple



Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *